Cargando…
Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases
BACKGROUND: Seronegative rheumatoid arthritis is associated with a milder course of progression compared to seropositive disease. However, long-term follow-up data of the clinical course of seronegative rheumatoid arthritis are sparse. Here we describe four cases with a rare disease entity of aggres...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891827/ https://www.ncbi.nlm.nih.gov/pubmed/27256084 http://dx.doi.org/10.1186/s12891-016-1067-y |
_version_ | 1782435333025038336 |
---|---|
author | Nikiphorou, Elena Sjöwall, Christopher Hannonen, Pekka Rannio, Tuomas Sokka, Tuulikki |
author_facet | Nikiphorou, Elena Sjöwall, Christopher Hannonen, Pekka Rannio, Tuomas Sokka, Tuulikki |
author_sort | Nikiphorou, Elena |
collection | PubMed |
description | BACKGROUND: Seronegative rheumatoid arthritis is associated with a milder course of progression compared to seropositive disease. However, long-term follow-up data of the clinical course of seronegative rheumatoid arthritis are sparse. Here we describe four cases with a rare disease entity of aggressive destructive seronegative (rheumatoid) arthritis with 20-35 years of follow-up. CASE PRESENTATION: The four cases are women with an initial presentation of seronegative rheumatoid arthritis in 1980-1996 and have received disease-modifying anti-rheumatic drugs since the diagnosis. In all cases, the condition has been refractory to treatments and evolved into a severe disease with destructions of the wrists, sub-talar and ankle joints, as well as large joints but not small joints of fingers and toes. All cases are negative with regard to rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antibodies against carbamylated proteins. CONCLUSIONS: This report adds to the existing literature, making the reader aware of this sub-type of inflammatory arthritis which despite being seronegative, can have devastating disease consequences. The report highlights the need for further research into this field in order to better understand this disease sub-type, the pathogenesis, disease course and outcomes. |
format | Online Article Text |
id | pubmed-4891827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48918272016-06-04 Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases Nikiphorou, Elena Sjöwall, Christopher Hannonen, Pekka Rannio, Tuomas Sokka, Tuulikki BMC Musculoskelet Disord Case Report BACKGROUND: Seronegative rheumatoid arthritis is associated with a milder course of progression compared to seropositive disease. However, long-term follow-up data of the clinical course of seronegative rheumatoid arthritis are sparse. Here we describe four cases with a rare disease entity of aggressive destructive seronegative (rheumatoid) arthritis with 20-35 years of follow-up. CASE PRESENTATION: The four cases are women with an initial presentation of seronegative rheumatoid arthritis in 1980-1996 and have received disease-modifying anti-rheumatic drugs since the diagnosis. In all cases, the condition has been refractory to treatments and evolved into a severe disease with destructions of the wrists, sub-talar and ankle joints, as well as large joints but not small joints of fingers and toes. All cases are negative with regard to rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antibodies against carbamylated proteins. CONCLUSIONS: This report adds to the existing literature, making the reader aware of this sub-type of inflammatory arthritis which despite being seronegative, can have devastating disease consequences. The report highlights the need for further research into this field in order to better understand this disease sub-type, the pathogenesis, disease course and outcomes. BioMed Central 2016-06-03 /pmc/articles/PMC4891827/ /pubmed/27256084 http://dx.doi.org/10.1186/s12891-016-1067-y Text en © Nikiphorou et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Nikiphorou, Elena Sjöwall, Christopher Hannonen, Pekka Rannio, Tuomas Sokka, Tuulikki Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title | Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title_full | Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title_fullStr | Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title_full_unstemmed | Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title_short | Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
title_sort | long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891827/ https://www.ncbi.nlm.nih.gov/pubmed/27256084 http://dx.doi.org/10.1186/s12891-016-1067-y |
work_keys_str_mv | AT nikiphorouelena longtermoutcomesofdestructiveseronegativerheumatoidarthritisdescriptionoffourclinicalcases AT sjowallchristopher longtermoutcomesofdestructiveseronegativerheumatoidarthritisdescriptionoffourclinicalcases AT hannonenpekka longtermoutcomesofdestructiveseronegativerheumatoidarthritisdescriptionoffourclinicalcases AT ranniotuomas longtermoutcomesofdestructiveseronegativerheumatoidarthritisdescriptionoffourclinicalcases AT sokkatuulikki longtermoutcomesofdestructiveseronegativerheumatoidarthritisdescriptionoffourclinicalcases |